This book explores the relationship between the gut microbiome and
cancer, illuminating various facets from fundamental roles to
personalized therapies. It provides a comprehensive overview of the
impact of the gut microbiome on cancer development, offering potential
for innovative diagnostic and treatment approaches. The book discusses
the role of dysbiosis in cancer development, the influence of the
microbiome on treatment responses, and strategies to modulate the
microbiome for enhanced therapies. It reviews the influence of the gut
microbiome on immunotherapy resistance and chemoresistance in cancer
patients. Additionally, the book presents gut microbiome biomarkers
for cancer diagnosis and prognosis, the implication of the gut-brain
axis on cancer development and progression, and the impact of diet and
lifestyle on the microbiome. Towards the end, the book investigates
the role of the gut microbiome in pediatric cancer and provides an
outlook on the future challenges, technological advancements, and
ethical considerations of gut microbiome research in the context of
personalized cancer therapies. This book is intended for cancer
researchers, medical oncologists, clinicians, pharmacologists,
translational investigators, and medical students.
Les mer
From Biomarkers to Personalized Therapies
Produktdetaljer
ISBN
9781040099902
Publisert
2024
Utgave
1. utgave
Utgiver
Vendor
CRC Press
Språk
Product language
Engelsk
Format
Product format
Digital bok
Forfatter